FDA Eases Path for Some Peptide Compounds Amid Safety Debate
The federal government has moved to make some compounded peptide products more available even as FDA staff have warned the evidence for safety and effectiveness is thin.
What consumers should know about unregulated peptide products
A Washington Post report highlights people who say they felt worse after using experimental peptides, while FDA warnings underline that many of these products have not been proven safe or effective.